Uveitis Terminated Phase 2 Trials for Tocilizumab (DB06273)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03554161Tocilizumab for the Treatment of Refractory Behcet's UveitisTreatment